Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study advances CAR T cell therapy targeted at cancer

Study advances CAR T cell therapy targeted at cancer

Study identifies molecular mechanism by which HSPCs recover after chemotherapy-induced injury

Study identifies molecular mechanism by which HSPCs recover after chemotherapy-induced injury

Engineered safety switch reduces CAR-T immunotherapy-related side effects

Engineered safety switch reduces CAR-T immunotherapy-related side effects

Cre-controlled CRISPR makes conditional gene inactivation more easier

Cre-controlled CRISPR makes conditional gene inactivation more easier

Research links blood-clotting protein with CNS B-cell lymphoma growth

Research links blood-clotting protein with CNS B-cell lymphoma growth

Hyperactive RANK protein could trigger autoimmune diseases

Hyperactive RANK protein could trigger autoimmune diseases

Yale scientists discover novel metabolic gatekeeper mechanism for leukemia

Yale scientists discover novel metabolic gatekeeper mechanism for leukemia

Two enzymes drive pre-cancer stem cells into malignancy

Two enzymes drive pre-cancer stem cells into malignancy

Drug-resistant, metastasis-causing cells produce exponentially growing tumors

Drug-resistant, metastasis-causing cells produce exponentially growing tumors

New CAR T therapy could be more effective and less toxic against neuroblastoma

New CAR T therapy could be more effective and less toxic against neuroblastoma

Protein phosphatase inhibition could contribute to the treatment of cancer, other diseases

Protein phosphatase inhibition could contribute to the treatment of cancer, other diseases

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Mice infused with CD5-deleted CAR T cells showed significant reduction in tumor size

Mice infused with CD5-deleted CAR T cells showed significant reduction in tumor size

Researchers target pathogenic T cells that could lead to new immunotherapy treatments

Researchers target pathogenic T cells that could lead to new immunotherapy treatments

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Scientists reveal health benefits of clonal hematopoiesis in allogeneic transplants

Scientists reveal health benefits of clonal hematopoiesis in allogeneic transplants

CAR T cells display signs of efficacy against hard-to-treat pediatric cancer in phase 1 trial

CAR T cells display signs of efficacy against hard-to-treat pediatric cancer in phase 1 trial

Cell survival protein could protect the kidneys from 'bystander' damage during cancer therapy

Cell survival protein could protect the kidneys from 'bystander' damage during cancer therapy

New way to predict who will respond to cancer therapies that block Wnt production

New way to predict who will respond to cancer therapies that block Wnt production

Discovering a new step in immune cell generation

Discovering a new step in immune cell generation